leisure time -WSS

leisure time

author：comprehensive 2025-09-30 01:19:44 - browse：498

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Weight bias in eating disorder treatment complicated by new weight loss drugs

focus

WSS

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Weight bias in eating disorder treatment complicated by new weight loss drugs

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Former Georgia lieutenant governor says he received grand jury subpoena

3 hurdles to bringing medical devices to the U.S. market

What would happen to your eyes if you looked at the solar eclipse?

hotspot

leisure time

Wikipedia

Heart attack and stroke risk calculators need revising

Gene therapy has helped boys walk. Can scientists keep it that way?

Apple is now the first public company to be valued at $3 trillion

With FDA staff opposed to Sarepta therapy, top official intervened

At least 13 dead in Texas as scorching temps continue

CDC concerned about possible undetected monkeypox spread in U.K.

Trump demands the U.S. pay no more for drugs than other countries … again

More regulation could be coming for drug ads

Medicare details structure of new drug price negotiation program

The battle over the Brookhaven Landfill on Long Island

explore

More regulation could be coming for drug ads

Biden praises World Series champion Astros for impact off the field during White House celebration

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

The story of mRNA: From a loose idea to a tool that may help curb Covid

Disclosing genetic information: not as worrisome as once feared

entertainment

focus

leisure time

hotspot